{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:19:24Z","timestamp":1761488364781},"reference-count":42,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2073,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/j.1600-0404.2009.01309.x","type":"journal-article","created":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T07:07:51Z","timestamp":1261984071000},"page":"270-277","source":"Crossref","is-referenced-by-count":14,"title":["Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer\u2019s disease"],"prefix":"10.1155","volume":"122","author":[{"given":"K.","family":"Wesnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Annas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Basun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lannfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1041610200006359","article-title":"Tracking cognitive decline in Alzheimer\u2019s disease using the mini-mental state examination: a meta-analysis","volume":"12","author":"Han","year":"2000","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archneur.64.9.1323","article-title":"A neuropsychological test battery for use in Alzheimer disease clinical trials","volume":"64","author":"Harrison","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-2008-15312","article-title":"Administration and scoring variance on the ADAS-Cog","volume":"15","author":"Connor","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB6|cit6","unstructured":"CPMP Guideline on medicinal products for the treatment of Alzheimer\u2019s disease and other dementias http:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/055395en.pdf (accessed on 28 May, 2009)"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/WNL.44.7.1215","article-title":"Age at onset of Alzheimer\u2019s disease: relation to pattern of cognitive dysfunction and rate of decline","volume":"44","author":"Jacobs","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"M65","DOI":"10.1093\/gerona\/54.2.M65","article-title":"The rate of decline in function in Alzheimer\u2019s disease and other dementias","volume":"54","author":"Mitnitski","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/archneur.61.12.1852","article-title":"Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","volume":"61","author":"Seltzer","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.wad.0000127445.00442.a1","article-title":"Disease stage in Alzheimer disease and treatment effects of rivastigmine","volume":"18","author":"Kurz","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.2003.029074","article-title":"Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer\u2019s disease","volume":"75","author":"Rockwood","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00002093-200110000-00003","article-title":"The Alzheimer\u2019s disease assessment scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer\u2019s disease","volume":"15","author":"Doraiswamy","year":"2001","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4088\/JCP.v68n0313","article-title":"Study design factors and patient demographics and their effect on the decline of placebo-treated subjects in randomized clinical trials in Alzheimer\u2019s disease","volume":"68","author":"Gold","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB14|cit14","first-page":"T167","volume-title":"No secular trend and high variability for ADAS-cog change among placebo groups from clinical trials. Alzheimer\u2019s Dement","volume":"4","author":"Schneider","year":"2008"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/gps.930060208","article-title":"The cognitive drug research computerised assessment system for demented subjects: a validation study","volume":"6","author":"Simpson","year":"1991","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002130000533","article-title":"The memory enhancing effects of a Ginkgo biloba\/Panax ginseng combination in healthy middle-aged volunteers","volume":"152","author":"Wesnes","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system","volume":"13","author":"Wesnes","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1185\/030079905X61884","article-title":"Early onset effects of galantamine treatment on attention in patients with Alzheimer\u2019s disease","volume":"21","author":"Vellas","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WAD.0b013e3181630b81","article-title":"Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil","volume":"22","author":"Galvin","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl. 3","key":"10.1111\/j.1600-0404.2009.01309.x-BIB20|cit20","first-page":"34","article-title":"Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines","volume":"11","author":"Ferris","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.03.064","article-title":"Longitudinal stability of CSF biomarkers in Alzheimer\u2019s disease","volume":"419","author":"Blennow","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","article-title":"Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration","volume":"566","author":"Li","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000107099","article-title":"Reduction of phosphorylated tau during memantine treatment of Alzheimer\u2019s disease","volume":"24","author":"Degerman Gunnarsson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB24|cit24","volume-title":"A quick test of cognitive speed (AQT)","author":"Wiig","year":"2002"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02244644","article-title":"Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer\u2019s disease: assessment of attentional and mnemonic function using CANTAB","volume":"110","author":"Sahakian","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000051269","article-title":"Early detection and differential diagnosis of Alzheimer\u2019s disease and depression with neuropsychological tasks","volume":"12","author":"Swainson","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(02)00236-3","article-title":"Practice effects on cognitive tasks: a major problem?","volume":"1","author":"Wesnes","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB28|cit28","article-title":"The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease","author":"Wiig","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archneur.56.7.857","article-title":"Variability in annual Mini-mental state examination score in patients with probable Alzheimer disease: a clinical perspective of data from the consortium to establish a Registry for Alzheimer\u2019s disease","volume":"56","author":"Clark","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.55.11.1609","article-title":"Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-mental state examination","volume":"55","author":"Dufouil","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1401::AID-SIM432>3.0.CO;2-X","article-title":"Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer\u2019s disease","volume":"19","author":"Mohs","year":"2000","journal-title":"Stat Med"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.61.1.59","article-title":"Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","volume":"61","author":"Grundman","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB34|cit34","unstructured":"Wesnes K Harrison J Edgar C Pincock C The sensitivity and reliability of the cognitive drug research computerised cognitive assessment system to disease progression and treatment response in Alzheimer \u2019 s disease 2005 17 154"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S1041610296002761","article-title":"Utility of clinical trial batteries in the measurement of Alzheimer\u2019s and Huntington\u2019s dementia","volume":"8","author":"Mohr","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1212\/WNL.54.8.1616","article-title":"Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia","volume":"54","author":"Walker","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/01.WNL.0000036908.39696.FD","article-title":"Fluctuations in attention: PD dementia vs DLB with parkinsonism","volume":"59","author":"Ballard","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1532-5415.1997.tb01002.x","article-title":"Bridging study of S12024 in 53 in-patients with Alzheimer\u2019s disease","volume":"45","author":"Allain","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"Mckeith","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/gps.1035","article-title":"Cross-national comparison and validation of the Alzheimer\u2019s disease assessment scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID)","volume":"19","author":"Verhey","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2009.01309.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1532-5415.2007.01379.x","article-title":"A comparison of computerized and pencil-and-paper tasks in assessing cognitive function in community-dwelling older people in the Newcastle 85+ Pilot Study","volume":"55","author":"Collerton","year":"2007","journal-title":"J Am Geriatr Soc"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2009.01309.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2009.01309.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:48:27Z","timestamp":1671540507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2009.01309.x"}},"subtitle":["Computerized cognition assessment in AD clinical trials"],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01309.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}